Publication:
Glofitamab in relapsed/refractory Diffuse Large B Cell Lymphoma: real world data

dc.conference.dateDEC 10-13, 2022
dc.conference.locationNew Orleans, LA
dc.conference.organizer64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)
dc.contributor.coauthorGulbas, Zafer
dc.contributor.coauthorUzay, Ant
dc.contributor.coauthorOzcan, Muhit
dc.contributor.coauthorOzkalemkas, Fahir
dc.contributor.coauthorDal, Mehmet Sinan
dc.contributor.coauthorDeveci, Burak
dc.contributor.coauthorBekoz, Huseyin
dc.contributor.coauthorSevindik, Omur Gokmen
dc.contributor.coauthorToptas, Tayfur
dc.contributor.coauthorYilmaz, Asu Fergun
dc.contributor.coauthorKoyun, Derya
dc.contributor.coauthorAlkis, Nihan
dc.contributor.departmentSchool of Medicine
dc.contributor.facultymemberYes
dc.contributor.kuauthorFerhanoğlu, Ahmet Burhan
dc.contributor.kuauthorKalyon, Hakan
dc.contributor.kuauthorAkay, Olga Meltem
dc.contributor.kuauthorBirtaş Ateşoğlu, Elif
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T23:25:53Z
dc.date.issued2022
dc.description.fulltextNo
dc.description.harvestedfromManual
dc.description.indexedbyWOS
dc.description.openaccessYES
dc.description.peerreviewstatusN/A
dc.description.publisherscopeInternational
dc.description.readpublishN/A
dc.description.sponsoredbyTubitakEuN/A
dc.description.studentonlypublicationNo
dc.description.studentpublicationNo
dc.description.versionN/A
dc.identifier.doi10.1182/blood-2022-165385
dc.identifier.eissn1528-0020
dc.identifier.embargoN/A
dc.identifier.endpage6705
dc.identifier.issn0006-4971
dc.identifier.quartileQ1
dc.identifier.startpage6704
dc.identifier.urihttps://doi.org/10.1182/blood-2022-165385
dc.identifier.urihttps://hdl.handle.net/20.500.14288/11459
dc.identifier.volume140
dc.identifier.wos000893223206319
dc.keywordsBispecific antibodies
dc.keywordsCombination drug therapy
dc.keywordsLymphoma large B-cell diffuse
dc.language.isoeng
dc.publisherAmerican Society of Hematology (ASH)
dc.relation.affiliationKoç University
dc.relation.collectionKoç University Institutional Repository
dc.relation.ispartofBlood
dc.relation.openaccessN/A
dc.rightsN/A
dc.subjectHematology
dc.titleGlofitamab in relapsed/refractory Diffuse Large B Cell Lymphoma: real world data
dc.typeMeeting Abstract
dspace.entity.typePublication
local.contributor.kuauthorFerhanoğlu, Ahmet Burhan
local.contributor.kuauthorKalyon, Hakan
local.contributor.kuauthorAkay, Olga Meltem
local.contributor.kuauthorBirtaş Ateşoğlu, Elif
relation.isGoalOfPublicationa9786601-9431-4553-9a46-013bb366fb87
relation.isGoalOfPublication.latestForDiscoverya9786601-9431-4553-9a46-013bb366fb87
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files